Cite
RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21
MLA
Dan Shu, et al. “RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic MiR-21.” Molecular Therapy, vol. 25, July 2017, pp. 1544–55. EBSCOhost, https://doi.org/10.1016/j.ymthe.2016.11.016.
APA
Dan Shu, Jun Ge Yu, Hui-Lung Sun, Matthew O. Old, Carlo M. Croce, Ri Cui, Tae Jin Lee, Peixuan Guo, Jianying Zhang, Mario Acunzo, Hui Li, Balveen Kaur, Zhenghua Luo, Ji Young Yoo, Alena Cristina Jaime-Ramirez, & Giulia Romano. (2017). RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21. Molecular Therapy, 25, 1544–1555. https://doi.org/10.1016/j.ymthe.2016.11.016
Chicago
Dan Shu, Jun Ge Yu, Hui-Lung Sun, Matthew O. Old, Carlo M. Croce, Ri Cui, Tae Jin Lee, et al. 2017. “RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic MiR-21.” Molecular Therapy 25 (July): 1544–55. doi:10.1016/j.ymthe.2016.11.016.